Carole Escartin

The promise of reactive astrocytes as biomarkers 3:01
The promise of reactive astrocytes as biomarkers
Carole Escartin • 27 Jul 2022
Neurotoxic versus neuroprotective astrocytes: is it that simple? 2:32
Neurotoxic versus neuroprotective astrocytes: is it that simple?
Carole Escartin • 27 Sep 2022
Reactive astrocytes as therapeutic targets in neurodegenerative disease 2:20
Reactive astrocytes as therapeutic targets in neurodegenerative disease
Carole Escartin • 27 Jul 2022
Can astrocytes influence neuropsychiatric symptoms in neurodegenerative disease? 1:41
Can astrocytes influence neuropsychiatric symptoms in neurodegenerative disease?
Carole Escartin • 27 Jul 2022
Reactive astrocytes show opposing functions in Alzheimer’s disease and Huntington’s disease 3:00
Reactive astrocytes show opposing functions in Alzheimer’s disease and Huntington’s disease
Carole Escartin • 27 Jul 2022
How is astrocyte reactivity controlled? 1:27
How is astrocyte reactivity controlled?
Carole Escartin • 27 Jul 2022
The content of VJDementia is intended for healthcare professionals